A successful combination of upadacitinib and guselkumab in refractory psoriasis and psoriatic arthritis: A case report
Monotherapy may not be sufficient for the complete control of the psoriatic disease in selected patients. In refractory patients, combining two drugs with different mechanisms of action may result in improved efficacy. Data regarding the combination of biologics and Janus kinase inhibitors are lacki...
| Published in: | SAGE Open Medical Case Reports |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Online Access: | https://doi.org/10.1177/2050313X251352160 |